118 related articles for article (PubMed ID: 10612591)
1. Structure-activity study of estrogenic agonists bearing dicarba-closo-dodecaborane. Effect of geometry and separation distance of hydroxyl groups at the ends of molecules.
Endo Y; Iijima T; Amakoshi Y; Kubo A; Itai A
Bioorg Med Chem Lett; 1999 Dec; 9(23):3313-8. PubMed ID: 10612591
[TBL] [Abstract][Full Text] [Related]
2. Estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
Endo Y; Yoshimi T; Iijima T; Yamakoshi Y
Bioorg Med Chem Lett; 1999 Dec; 9(24):3387-92. PubMed ID: 10617077
[TBL] [Abstract][Full Text] [Related]
3. New estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
Endo Y; Yoshimi T; Yamakoshi Y
Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):312-4. PubMed ID: 10705532
[TBL] [Abstract][Full Text] [Related]
4. Potent estrogen agonists based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters.
Endo Y; Iijima T; Yamakoshi Y; Fukasawa H; Miyaura C; Inada M; Kubo A; Itai A
Chem Biol; 2001 Apr; 8(4):341-55. PubMed ID: 11325590
[TBL] [Abstract][Full Text] [Related]
5. Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
Endo Y; Iijima T; Yamakoshi Y; Yamaguchi M; Fukasawa H; Shudo K
J Med Chem; 1999 May; 42(9):1501-4. PubMed ID: 10229620
[No Abstract] [Full Text] [Related]
6. Dicarba-closo-dodecaboranes as a pharmacophore. Novel potent retinoidal agonists.
Endo Y; Iijima T; Kagechika H; Ohta K; Kawachi E; Shudo K
Chem Pharm Bull (Tokyo); 1999 Apr; 47(4):585-7. PubMed ID: 10319433
[TBL] [Abstract][Full Text] [Related]
7. Utility of boron clusters for drug design. Relation between estrogen receptor binding affinity and hydrophobicity of phenols bearing various types of carboranyl groups.
Endo Y; Yamamoto K; Kagechika H
Bioorg Med Chem Lett; 2003 Nov; 13(22):4089-92. PubMed ID: 14592514
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C modulators bearing dicarba-CLOSO-dodecaborane as a hydrophobic pharmacophore.
Endo Y; Yoshimi T; Kimura K; Itai A
Bioorg Med Chem Lett; 1999 Sep; 9(17):2561-4. PubMed ID: 10498208
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of p-carborane bisphenols and their derivatives: structure-activity relationship for estrogenic activity.
Ogawa T; Ohta K; Iijima T; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2009 Feb; 17(3):1109-17. PubMed ID: 19141368
[TBL] [Abstract][Full Text] [Related]
10. Dicarba-closo-dodecaboranes as a pharmacophore. Retinoidal antagonists and potential agonists.
Iijima T; Endo Y; Tsuji M; Kawachi E; Kagechika H; Shudo K
Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):398-404. PubMed ID: 10212389
[TBL] [Abstract][Full Text] [Related]
11. Utility of boron clusters for drug design. Hansch-fujita hydrophobic parameters pi of dicarba-closo-dodecaboranyl groups.
Yamamoto K; Endo Y
Bioorg Med Chem Lett; 2001 Sep; 11(17):2389-92. PubMed ID: 11527738
[TBL] [Abstract][Full Text] [Related]
12. Modulators of tumor necrosis factor alpha production bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
Tsuji M; Koiso Y; Takahashi H; Hashimoto Y; Endo Y
Biol Pharm Bull; 2000 Apr; 23(4):513-6. PubMed ID: 10784439
[TBL] [Abstract][Full Text] [Related]
13. Novel retinoid X receptor (RXR) antagonists having a dicarba-closo-dodecaborane as a hydrophobic moiety.
Ohta K; Iijima T; Kawachi E; Kagechika H; Endo Y
Bioorg Med Chem Lett; 2004 Dec; 14(23):5913-8. PubMed ID: 15501068
[TBL] [Abstract][Full Text] [Related]
14. Anti-mycobacterial activity of thymine derivatives bearing boron clusters.
Adamska A; Rumijowska-Galewicz A; Ruszczynska A; Studzińska M; Jabłońska A; Paradowska E; Bulska E; Munier-Lehmann H; Dziadek J; Leśnikowski ZJ; Olejniczak AB
Eur J Med Chem; 2016 Oct; 121():71-81. PubMed ID: 27236064
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of tetraol derivatives of 1,12-dicarba-closo-dodecaborane as non-secosteroidal vitamin D analogs.
Fujii S; Kano A; Masuno H; Songkram C; Kawachi E; Hirano T; Tanatani A; Kagechika H
Bioorg Med Chem Lett; 2014 Sep; 24(18):4515-4519. PubMed ID: 25149512
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure, docking study and structure-activity relationship of carborane-containing androgen receptor antagonist 3-(12-hydroxymethyl-1,12-dicarba-closo-dodecaboran-1-yl)benzonitrile.
Ohta K; Goto T; Fujii S; Kawahata M; Oda A; Ohta S; Yamaguchi K; Hirono S; Endo Y
Bioorg Med Chem; 2011 Jun; 19(11):3540-8. PubMed ID: 21536446
[TBL] [Abstract][Full Text] [Related]
17. Structure-Activity study of retinoid agonists bearing substituted dicarba-closo-dodecaborane. Relation between retinoidal activity and conformation of two aromatic nuclei.
Endo Y; Iijima T; Yaguchi K; Kawachi E; Inoue N; Kagechika H; Kubo A; Itai A
Bioorg Med Chem Lett; 2001 May; 11(10):1307-11. PubMed ID: 11392543
[TBL] [Abstract][Full Text] [Related]
18. Potent androgen antagonists based on carborane as a hydrophobic core structure.
Fujii S; Goto T; Ohta K; Hashimoto Y; Suzuki T; Ohta S; Endo Y
J Med Chem; 2005 Jul; 48(14):4654-62. PubMed ID: 16000001
[TBL] [Abstract][Full Text] [Related]
19. Novel iodinated carboranes: synthesis of the 8-iodo-7,9-dicarba-nido-undecaborate anion and 2-iodo-1,7-dicarba-closo-dodecaborane.
Safronov AV; Kabytaev KZ; Jalisatgi SS; Hawthorne MF
Dalton Trans; 2014 Sep; 43(33):12467-9. PubMed ID: 24782077
[TBL] [Abstract][Full Text] [Related]
20. Modulation of human neutrophil activity by adenosine modified with a carborane pharmacophore.
Bednarska K; Olejniczak AB; Klink M; Sułowska Z; Leśnikowski ZJ
Bioorg Med Chem Lett; 2014 Jul; 24(14):3073-8. PubMed ID: 24881569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
